ALXO vs DHR · $207.2M cap vs P/E 39, rev $6.26B
Alx Oncology Holdings (ALXO) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US. It is led by Rainer M. Blair.
ALXO does not have a complete income-statement cache yet.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
ALXO currently screens at market cap $207.2M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the ALXO and DHR stock pages for the full models.
Not investment advice.